C-reactive protein can predict dose intensity, time to treatment failure and overall survival in HCC treated with lenvatinib

• Tsuguru Hayashi ,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Writing – original draft

  * E-mail: haya033185@med.uoeh-u.ac.jp

  Affiliation Third Department of Internal Medicine, University of Occupational and Environmental health, Fukuoka, Japan

  https://orcid.org/0000-0002-3312-1672

  ⨯
• Michihiko Shibata,

  Roles Conceptualization, Project administration, Writing – original draft, Writing – review & editing

  Affiliation Third Department of Internal Medicine, University of Occupational and Environmental health, Fukuoka, Japan

  ⨯
• Shinji Oe,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Third Department of Internal Medicine, University of Occupational and Environmental health, Fukuoka, Japan

  ⨯
• Koichiro Miyagawa,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Third Department of Internal Medicine, University of Occupational and Environmental health, Fukuoka, Japan

  ⨯
• Yuichi Honma,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Third Department of Internal Medicine, University of Occupational and Environmental health, Fukuoka, Japan

  ⨯
• Masaru Harada

  Roles Project administration, Writing – original draft, Writing – review & editing

  Affiliation Third Department of Internal Medicine, University of Occupational and Environmental health, Fukuoka, Japan

  ⨯